Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Smith Karen L. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/21/2023 4 Smith Karen L. (Director) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Granted 17,913 restricted stock units @ $0
Granted 28,959 options to buy @ $9.49, valued at $274.8k
08/21/2023 3 Smith Karen L. (Director) has filed a Form 3 on Aurinia Pharmaceuticals Inc.
06/05/2023 4 Smith Karen L. (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC
Txns: Granted 13,900 shares @ $0
Granted 27,750 options to buy @ $1.11, valued at $30.8k
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4/A Smith Karen L. (Chief Medical Officer) has filed a Form 4 on Cortexyme, Inc.
Txns: Granted 170,354 shares @ $0
05/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/23/2022 4 Smith Karen L. (Chief Medical Officer) has filed a Form 4 on Cortexyme, Inc.
Txns: Granted 24,336 shares @ $0
Granted 151,799 options to buy @ $0.55, valued at $83.5k
Granted 1,365,449 options to buy @ $2.98, valued at $4.1M
05/23/2022 3 Smith Karen L. (Chief Medical Officer) has filed a Form 3 on Cortexyme, Inc.
05/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
03/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/22/2021 4 Smith Karen L. (Director) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Unknown transaction of 1,622 shares @ $0
Disposed/sold 10,000 options to buy @ $35.34, valued at $353.4k
Disposed/sold 1,875 options to buy @ $40.61, valued at $76.1k
Disposed/sold 3,750 options to buy @ $41.64, valued at $156.2k
Disposed/sold 4,085 options to buy @ $52.99, valued at $216.5k
Disposed/sold 3,222 options to buy @ $115.53, valued at $372.2k
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2020 4 Smith Karen L. (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 30,220 shares @ $2.73, valued at $82.5k
Granted 58,246 options to buy @ $2.73, valued at $159k
06/03/2020 4/A Smith Karen L. (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC
Txns: Granted 10,000 shares @ $0
Granted 20,000 options to buy @ $10.46, valued at $209.2k
05/28/2020 3 Smith Karen L. (EVP, Chief Medical Officer) has filed a Form 3 on Emergent BioSolutions Inc.
05/20/2020 4 Smith Karen L. (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC
Txns: Granted 2,500 shares @ $0
Granted 15,000 options to buy @ $10.46, valued at $156.9k
01/24/2020 4 Smith Karen L. (Director) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Granted 1,377 shares @ $0
Granted 8,185 options to buy @ $52.99, valued at $433.7k
06/14/2019 4 Smith Karen L. (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 23,973 shares @ $2.92, valued at $70k
Granted 46,729 options to buy @ $2.92, valued at $136.4k
06/12/2019 4 Smith Karen L. (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC
Txns: Granted 2,500 shares @ $0
Granted 15,000 options to buy @ $9.38, valued at $140.7k
03/05/2019 4 Smith Karen L. (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 20,000 options to buy @ $3.72, valued at $74.4k
03/05/2019 3 Smith Karen L. (Director) has filed a Form 3 on ANTARES PHARMA, INC.
01/29/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/28/2018 4 Smith Karen L. (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC
Txns: Granted 5,000 shares @ $0
Granted 30,000 options to buy @ $15.65, valued at $469.5k
06/28/2018 3 Smith Karen L. (Director) has filed a Form 3 on SANGAMO THERAPEUTICS, INC
03/07/2018 4 Smith Karen L. (EVP, R&D and CMO) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Paid exercise price by delivering 648 shares @ $143.39, valued at $92.9k
03/05/2018 4 Smith Karen L. (Director) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Granted 312 shares @ $0
Granted 1,875 options to buy @ $40.61, valued at $76.1k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy